Healthcare -
Biotechnology - NASDAQ - US
$ 1.045
-6.7 %
$ 119 M
Market Cap
-0.64
P/E
FATE - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative FATE - Fate Therapeutics, Inc.
79.4 M
LAST VALUE
17.73%
2 YEAR CAGR
38.12%
5 YEAR CAGR
28.17%
10 YEAR CAGR